33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparative effectiveness of bladder-preserving tri-modality therapy versus radical cystectomy for muscle-invasive bladder cancer
    Meeting Abstract

    Royce, T. J.; Feldman, A. S.; Mossanen, M.; Yang, J. C.; Shipley, W. U.; Pandharipande, P. V.; Efstathiou, J. A.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Updated acute and late gastrointestinal and genitourinary toxicity of dose-escalated image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon
    Meeting Abstract

    Montoya, C.; Deville, C. Jr; Vapiwala, N.; Both, S.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • A phase I trial of dose-escalated image-guided, intensity modulated radiation therapy in combination with concurrent gemcitabine chemotherapy for node-negative, muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Kollmeier, M. A.; Zelefsky, M. J.; McBride, S.; Debonis, D.; Lochansingh, S.; Varghese, M.; Bochner, B.; Rosenberg, J.; Bajorin, D.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • A phase II trial of low dose rate brachytherapy combined with ultra-hypofractionated, image-guided, intensity-modulated radiation therapy for clinically localized, intermediate risk prostate cancer: A preliminary analysis
    Meeting Abstract

    Kollmeier, M. A.; McBride, S.; Lochansingh, S.; Varghese, M.; Debonis, D.; Cohen, G.; Damato, A. L.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • The first prostate specific antigen value after androgen deprivation therapy initiation and after definitive radiation therapy completion as a biomarker for disease relapse and mortality in intermediate and high risk prostate cancer
    Meeting Abstract

    Patel, M. A.; Kollmeier, M. A.; McBride, S.; Gorovets, D.; Varghese, M.; Knezevic, A.; Zhigang, Z.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Prostate cancer and benign tissue response to hypofractionated SBRT monitored by multi-modality MRI over a 2 year period
    Meeting Abstract

    Zakian, K.; Wibmer, A.; Vargas, H. A.; Iyer, A.; Tyagi, N.; Apte, A.; Hunt, M. A.; Kollmeier, M. A.; Mychalczak, B. R.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Pathogenic mutations in ATM predict for enhanced local control in prostate cancers treated with radiation thearpy
    Meeting Abstract

    Lu, C.; Pitter, K. L.; Casey, D. L.; Riaz, N.; Lee, N.; McBride, S.; Reis-Filho, J.; Powell, S. N.; Zelefsky, M. J.; Chan, T. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Increased chemotherapy-induced ovarian reserve loss in women with BRCA mutations: A prospective longitudinal study with mechanistic confirmation
    Meeting Abstract

    Oktay, K.; Bedoschi, G.; Goldfarb, S.; Titus, S.; Palomaki, G.; Dickler, M.
    Fertility and Sterility (2018)

    Fulltext@MSK | Save
  • The value of somatostatin receptor scintigraphy (SRS) in patients with NETG1/G2 neuroendocrine neoplasms of the small intestine (SI-NENs)
    Meeting Abstract

    Konsek, S. J.; Kolasinska-Cwikla, A. D.; Lewczuk, A.; Kidd, M.; Buscombe, J. R.; Bodei, L.; Cichocki, A.; Roszkowska-Purska, K.; Cwikla, J. B.; Modlin, I. M.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Metabolic parameters measured by (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the outcome of patients with non-small cell lung cancer treated with pembrolizumab
    Meeting Abstract

    Nakajima, R.; Ito, K.; Weber, W.; Schoder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save